Linked Life Data

10907954

Source:http://linkedlifedata.com/resource/pubmed/id/10907954

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-12-28
pubmed:abstractText
Gemcitabine therapy has not been widely assessed in the treatment of hematological malignancies. We have examined the efficacy and safety of gemcitabine in patients with relapsed or resistant lymphoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
595-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Gemcitabine for relapsed or resistant lymphoma.
pubmed:affiliation
Hematology/Oncology Division, Columbia University, New York, New York 10032, USA. savage@cuccfa.ccc.columbia.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't